Reviva Pharmaceuticals (RVPH) Stock Chart & Stock Price History $1.78 +0.14 (+8.54%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Reviva Pharmaceuticals Stock Price Performance 5 Day Performance+32.84%1 Month Performance+54.78%3 Month Performance+37.98%6 Month Performance+41.27%Year-To-Date Performance-65.44%1 Year Performance-61.64% Receive RVPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address $19 for a FULL YEAR of stock picks?! (Ad)We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $19. But why? Because there is a very small window of time... as little as 25 days from now... That will change the market forever.Click here to get in now>>> RVPH Stock Chart for Thursday, December, 26, 2024 RVPH Chart by TradingView Reviva Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/25/2024$1.78$1.78$1.84$1.544.27 million shs$59.53 million12/24/2024$1.64$1.78+8.54%$1.84$1.544.27 million shs$59.53 million12/23/2024$1.34$1.64+22.39%$1.64$1.255.95 million shs$54.84 million12/20/2024$1.50$1.34-10.67%$1.51$1.234.44 million shs$44.81 million12/19/2024$1.44$1.50+4.53%$1.57$1.442.44 million shs$50.16 million12/18/2024$1.40$1.44+2.50%$1.75$1.405.44 million shs$47.99 million Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/17/2024$2.30$1.40-39.13%$1.59$1.2518.08 million shs$46.82 million12/16/2024$2.61$2.30-11.88%$2.74$2.259.32 million shs$76.91 million12/13/2024$2.77$2.61-5.78%$2.95$2.464.47 million shs$87.28 million12/12/2024$2.82$2.77-1.60%$2.95$2.623.44 million shs$92.63 million12/11/2024$2.52$2.82+11.71%$2.97$2.515.84 million shs$94.14 million12/10/2024$2.12$2.52+18.87%$2.99$2.219.66 million shs$84.27 million12/09/2024$1.65$2.12+28.48%$4.28$1.7321.93 million shs$70.89 million12/06/2024$1.43$1.65+15.38%$1.68$1.451.89 million shs$55.18 million12/05/2024$1.25$1.43+14.40%$1.48$1.211.69 million shs$47.82 million12/04/2024$1.18$1.25+5.93%$1.26$1.15480,335 shs$41.80 million12/03/2024$1.20$1.18-1.67%$1.23$1.15400,833 shs$39.46 million12/02/2024$1.24$1.20-3.23%$1.28$1.15360,772 shs$40.13 million11/29/2024$1.14$1.24+8.77%$1.26$1.14271,717 shs$41.47 million11/28/2024$1.14$1.14$1.22$1.11541,997 shs$38.12 million11/27/2024$1.12$1.14+1.79%$1.22$1.11541,997 shs$38.12 million11/26/2024$1.15$1.12-2.61%$1.16$1.09444,388 shs$37.45 million11/25/2024$1.14$1.15+0.88%$1.24$1.11437,621 shs$38.46 million Related Companies CMPX Stock Price Chart MGNX Stock Price Chart ATAI Stock Price Chart OGI Stock Price Chart ACRV Stock Price Chart SLN Stock Price Chart GOSS Stock Price Chart INZY Stock Price Chart ADCT Stock Price Chart CYBN Stock Price Chart Receive RVPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RVPH) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
